Ayşe Barış

Ayşe Barış


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
AKAhmet Furkan Furkan Kurt
Ahmet Furkan Furkan Kurt
MKMert Ahmet Kuskucu
Mert Ahmet Kuskucu
IBIiker Inanc Balkan
Iiker Inanc Balkan
ABAyşe Barış
Ayşe Barış
ZYZeynep Yazgan
Zeynep Yazgan
GAGokhan Aygun
Gokhan Aygun


17 December 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
RARABİYE ALTINBAŞ
RABİYE ALTINBAŞ
ABAyşe Barış
Ayşe Barış
SŞSümeyye Şen
Sümeyye Şen
RÖRecep Öztürk
Recep Öztürk
NKNuri Ki̇rAz
Nuri Ki̇rAz
The infections caused by Candida species are in significant increase today and invasive Candida infections are generally associated with high mortality. Early diagnosis and identification of Candida spp. are important for the determination of antifungal agents that will be used for treatment. The aim of the present study was to provide a better regimen for Candida infections in future. Sensititre YeastOne method was compared with The Clinical Laboratory Standards Institute reference broth microdilution testing method. Endpoints of minimal inhibitory concentrations (MICs) were determined for both methods. By using both methods, MIC values of micafungin, caspofungin, voriconazole, and fluconazole were lower than amphotericin B. The values obtained with Sensititre YeastOne method were in high categorical agreement for ecinocandins and amphotericin B. The results of voriconazole and fluconazole were in low categorical agreement. The categorical agreement between the SYO and the BMD results at 24 h was 82.1% for VORI and 98.4% for AMB. The values obtained with Sensititre YeastOne method for all antifungal agents were in high essential agreement with the data of Clinical Laboratory Standards Institute reference broth microdilution method. The essential agreement between the SYO and the BMD results at 24 h was 94.0% for MFG and 99.0% for AMB. The Sensititre YeastOne method was ready-to use so appeared to be easier and more efficient for Candida isolates.

29 April 2021 in Journal of Medical Microbiology
Verified
Journal Article
Open access
SKSümeyye Şen Kaya
Sümeyye Şen Kaya
NKNuri Kiraz
Nuri Kiraz
ABAyşe Barış
Ayşe Barış
DTDeniz Turan
Deniz Turan
YOYasemin Oz
Yasemin Oz
GAGökhan Aygün
Gökhan Aygün
Introduction. The simultaneous use of antifungals with immunosuppressive agents has become a necessity for patients taking immunosuppressive therapy. However, antifungal drugs are problematic because of their limited target. Hypothesis. Scientists have been searching for new antifungals and some compounds with at least additive effects on antifungals. Calcineurin inhibitors used as immunosuppressive agents also attract attention due to their antifungal property. Aim. To evaluate the activity of two calcineurin inhibitors alone and in combination with amphotericin B (AMB), caspofungin (CAS), itraconazole (ITR), voriconazole (VOR) and fluconazole (FLU). Methodology. MICs of AMB, CAS, ITR, VOR, FLU and cyclosporine A (CsA) and tacrolimus (TAC) as calcineurin inhibitors were evaluated by the broth microdilution method against Candida albicans (n=13), C. krusei (n=7) and C. glabrata (n=10). Checkerboard and time-kill methods were performed to investigate the activity of combining calcineurin inhibitors with antifungal drugs. Results. The lowest MIC values were detected with VOR for all Candida isolates tested. Although we did not detect any inhibition for CsA or TAC alone at concentrations tested in this study, the combinations of CAS with CsA showed the highest synergistic activity (36.7%) by the checkerboard method, and CAS with CsA and ITR with TAC combinations exhibited apparent synergistic interaction by the time-kill method. However, the combinations of both CsA and TAC with AMB resulted in antagonistic interactions, especially against C. krusei isolate in time-kill testing. Conclusion. Synergistic interactions in the combinations of TAC or CsA with antifungal drugs, except for AMB, in many concentrations was found to be promising in terms of the treatment of patients with fungal infections.


1 July 2021 in Medical Journal of Bakırkoy
Verified
Journal Article
Closed access
DTDeniz Turan
Deniz Turan
ABAyşe Barış
Ayşe Barış
FÖFatma Özakkaş
Fatma Özakkaş
ŞDŞölen Daldaban Dinçer
Şölen Daldaban Dinçer
SASebahat Aksaray
Sebahat Aksaray